Kazia Therapeutics KZIA
NASDAQ KZIA
$9.60 -0.15 (-1.59%)
At close: Sep 30, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) EBITDA (2009 - 2023)

Updated

Kazia Therapeutics' EBITDA was -$13.78 million in the year ended Jun 30, 2025.

Analysis

Kazia Therapeutics (KZIA) EBITDA (2009 - 2023) Analysis & Trends

From the year ended Dec 31, 2009 onward, Kazia Therapeutics has reported EBITDA for 17 years.

  • The figure for the year ended Jun 30, 2025 marks the lowest annual EBITDA in data going back to the year ended Dec 31, 2009.
  • Per Business Quant data, EBITDA in earlier years was -$5.7 million in the year ended Dec 31, 2024, -$4.62 million in the year ended Dec 31, 2023, -$8.24 million in the year ended Dec 31, 2022 and -$9.21 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 9.10 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 8.33 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 999.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 5.09 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 4.63 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -9.70 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 5.89 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.30 Bn
10 Kazia Therapeutics 71.87 Mn 71.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -12.89 Mn
Dec 31, 2013 -1.41 Mn
Aug 30, 2013 -5.24 Mn
Dec 31, 2012 -1.54 Mn
Dec 31, 2009 2.92 Mn
API Access

Kazia Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=KZIA&period=max&api_key=YOUR_API_KEY